Pharmosa Biopharm Inc. (TPEX: 6875)
Taiwan
· Delayed Price · Currency is TWD 63.40
-3.10 (-4.66%)
Sep 10, 2024, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 8.18 billion as of September 10, 2024. Its market cap has decreased by -21.99% in one year.
Market Cap
8.18B
Enterprise Value
6.56B
Revenue
324.12M
Ranking
n/a
PE Ratio
276.61
Stock Price
63.40
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 8.18B, an increase of 68.37%. That is a compound annual growth rate of 22.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2024 | 8.18B | -20.69% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition